Production (Stage)
Raia Drogasil S.A.
RADLY
$2.47
-$0.17-6.44%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.72B | 1.73B | 1.80B | 1.86B | 1.84B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.72B | 1.73B | 1.80B | 1.86B | 1.84B |
| Cost of Revenue | 1.22B | 1.21B | 1.27B | 1.30B | 1.30B |
| Gross Profit | 492.55M | 511.08M | 535.78M | 562.60M | 537.16M |
| SG&A Expenses | 411.48M | 421.25M | 420.54M | 435.19M | 430.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -6.52M | 6.16M | 4.66M | 1.76M | 122.20K |
| Total Operating Expenses | 1.63B | 1.64B | 1.69B | 1.73B | 1.73B |
| Operating Income | 87.59M | 83.66M | 110.59M | 125.65M | 106.32M |
| Income Before Tax | 34.23M | 47.71M | 79.51M | 79.80M | 56.57M |
| Income Tax Expenses | 6.03M | -11.84M | 18.35M | 16.74M | 17.52M |
| Earnings from Continuing Operations | 28.20M | 59.55M | 61.16M | 63.07M | 39.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -190.00K | 20.70K | -739.90K | -391.60K | -1.11M |
| Net Income | 28.01M | 59.57M | 60.42M | 62.67M | 37.94M |
| EBIT | 87.59M | 83.66M | 110.59M | 125.65M | 106.32M |
| EBITDA | 119.67M | 115.04M | 142.53M | 159.22M | 140.77M |
| EPS Basic | 0.02 | 0.04 | 0.04 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 |
| EPS Diluted | 0.02 | 0.04 | 0.04 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 |
| Average Basic Shares Outstanding | 1.65B | 1.65B | 1.65B | 2.87B | 1.65B |
| Average Diluted Shares Outstanding | 1.65B | 1.65B | 1.66B | 2.87B | 1.67B |
| Dividend Per Share | -- | -- | 0.02 | -- | -- |
| Payout Ratio | 0.06% | 67.74% | 0.33% | 72.67% | 0.10% |